139 related articles for article (PubMed ID: 34507289)
1. Severity, timeline, and management of complications after stereotactic brain biopsy.
Riche M; Marijon P; Amelot A; Bielle F; Mokhtari K; Chambrun MP; Joncour AL; Idbaih A; Touat M; Do CH; Deme M; Pasqualotto R; Jacquens A; Degos V; Shotar E; Chougar L; Carpentier A; Mathon B
J Neurosurg; 2022 Mar; 136(3):867-876. PubMed ID: 34507289
[TBL] [Abstract][Full Text] [Related]
2. Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesion.
Malaizé H; Laigle-Donadey F; Riche M; Marijon P; Mokhtari K; Bielle F; Tran S; Nichelli L; Beccaria K; Idbaih A; Hoang-Xuan K; Touat M; Carpentier A; Mathon B;
J Neurooncol; 2022 Oct; 160(1):159-170. PubMed ID: 36083426
[TBL] [Abstract][Full Text] [Related]
3. Haemorrhagic complications and the incidence of asymptomatic bleeding associated with stereotactic brain biopsies.
Grossman R; Sadetzki S; Spiegelmann R; Ram Z
Acta Neurochir (Wien); 2005 Jun; 147(6):627-31; discussion 631. PubMed ID: 15821863
[TBL] [Abstract][Full Text] [Related]
4. Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy.
Kulkarni AV; Guha A; Lozano A; Bernstein M
J Neurosurg; 1998 Jul; 89(1):31-5. PubMed ID: 9647169
[TBL] [Abstract][Full Text] [Related]
5. Postoperative management of patients after stereotactic biopsy: results of a survey of the AANS/CNS section on tumors and a single institution study.
Warnick RE; Longmore LM; Paul CA; Bode LA
J Neurooncol; 2003 May; 62(3):289-96. PubMed ID: 12777081
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive assessment of hemorrhage risks and outcomes after stereotactic brain biopsy.
Field M; Witham TF; Flickinger JC; Kondziolka D; Lunsford LD
J Neurosurg; 2001 Apr; 94(4):545-51. PubMed ID: 11302651
[TBL] [Abstract][Full Text] [Related]
7. Hemorrhage after stereotactic biopsy from intra-axial brain lesions: incidence and avoidance.
Shakal AA; Mokbel EA
J Neurol Surg A Cent Eur Neurosurg; 2014 May; 75(3):177-82. PubMed ID: 23526202
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of frameless and frame-based intracranial biopsy techniques.
Dammers R; Haitsma IK; Schouten JW; Kros JM; Avezaat CJ; Vincent AJ
Acta Neurochir (Wien); 2008 Jan; 150(1):23-9. PubMed ID: 18172567
[TBL] [Abstract][Full Text] [Related]
9. Clinical and economic consequences of early discharge of patients following supratentorial stereotactic brain biopsy.
Kaakaji W; Barnett GH; Bernhard D; Warbel A; Valaitis K; Stamp S
J Neurosurg; 2001 Jun; 94(6):892-8. PubMed ID: 11409516
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Brain Biopsy Hemorrhage Risk Factors and Implications for Postoperative Care at a Single Institution: An Argument For Postoperative Imaging.
Barkley AS; Sullivan LT; Gibson AW; Camacho D; Barber JK; Ko AL; Silbergeld DL; Ravanpay AC
World Neurosurg; 2020 Dec; 144():e807-e812. PubMed ID: 32956884
[TBL] [Abstract][Full Text] [Related]
11. Complications of MRI-guided stereotactic biopsy of brain lymphoma.
Malikova H; Liscak R; Latnerova I; Guseynova K; Syrucek M; Pytlik R
Neuro Endocrinol Lett; 2014; 35(7):613-8. PubMed ID: 25617885
[TBL] [Abstract][Full Text] [Related]
12. Complications after frame-based stereotactic brain biopsy: a systematic review.
Riche M; Amelot A; Peyre M; Capelle L; Carpentier A; Mathon B
Neurosurg Rev; 2021 Feb; 44(1):301-307. PubMed ID: 31900737
[TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of stereotactic biopsy for intracranial lesions.
Hall WA
Cancer; 1998 May; 82(9):1749-55. PubMed ID: 9576298
[TBL] [Abstract][Full Text] [Related]
14. Intraindividual comparison of histopathological diagnosis obtained by stereotactic serial biopsy to open surgical resection specimen in patients with intracranial tumours.
Reithmeier T; Lopez WO; Doostkam S; Machein MR; Pinsker MO; Trippel M; Nikkhah G
Clin Neurol Neurosurg; 2013 Oct; 115(10):1955-60. PubMed ID: 23769864
[TBL] [Abstract][Full Text] [Related]
15. Computed imaging-assisted stereotactic brain biopsy: a risk analysis of 225 consecutive cases.
Sawin PD; Hitchon PW; Follett KA; Torner JC
Surg Neurol; 1998 Jun; 49(6):640-9. PubMed ID: 9637625
[TBL] [Abstract][Full Text] [Related]
16. Frameless stereotaxy with scalp-applied fiducial markers for brain biopsy procedures: experience in 218 cases.
Barnett GH; Miller DW; Weisenberger J
J Neurosurg; 1999 Oct; 91(4):569-76. PubMed ID: 10507376
[TBL] [Abstract][Full Text] [Related]
17. Comparison of frame-less robotic versus frame-based stereotactic biopsy of intracranial lesions.
Spyrantis A; Woebbecke T; Constantinescu A; Cattani A; Quick-Weller J; Willems LM; Marquardt G; Seifert V; Freiman TM
Clin Neurol Neurosurg; 2021 Aug; 207():106762. PubMed ID: 34153776
[TBL] [Abstract][Full Text] [Related]
18. The risk of hemorrhage in stereotactic biopsy for brain tumors.
Mizobuchi Y; Nakajima K; Fujihara T; Matsuzaki K; Mure H; Nagahiro S; Takagi Y
J Med Invest; 2019; 66(3.4):314-318. PubMed ID: 31656296
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic biopsy of brainstem lesions: 21 years experiences of a single center.
Quick-Weller J; Lescher S; Bruder M; Dinc N; Behmanesh B; Seifert V; Weise L; Marquardt G
J Neurooncol; 2016 Sep; 129(2):243-50. PubMed ID: 27291894
[TBL] [Abstract][Full Text] [Related]
20. Complications in 622 cases of frame-based stereotactic biopsy, a decreasing procedure.
Kongkham PN; Knifed E; Tamber MS; Bernstein M
Can J Neurol Sci; 2008 Mar; 35(1):79-84. PubMed ID: 18380282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
